Potential of dry powder inhalers for tuberculosis therapy: facts, fidelity and future-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Potential of dry powder inhalers for tuberculosis therapy: facts, fidelity and future

Published:2018-10-11 Issue:sup3 Volume:46 Page:S791-S806
ISSN:2169-1401
Container-title:Artificial Cells, Nanomedicine, and Biotechnology
language:en
Short-container-title:Artificial Cells, Nanomedicine, and Biotechnology

Author:

Mehta Piyush¹,Bothiraja C.²,Kadam Shivajirao³,Pawar Atmaram²

Affiliation:

1. Department of Quality Assurance Technique, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed-to-be-University), Pune, India;

2. Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed-to-be-University), Pune, India;

3. Bharati Vidyapeeth Bhavan, Bharati Vidyapeeth (Deemed-to-be-University), Pune, India

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Biomedical Engineering,General Medicine,Medicine (miscellaneous),Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21691401.2018.1513938

Reference98 articles.

1. Recent advancements in the development of anti-tuberculosis drugs

2. New agents for the treatment of drug-resistant Mycobacterium tuberculosis

3. The long and winding road to inhaled TB therapy: not only the bug’s fault

4. The formulation of nanomedicines for treating tuberculosis

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a proliposomal pretomanid dry powder inhaler as a novel alternative approach for combating pulmonary tuberculosis;International Journal of Pharmaceutics;2024-10

2. Evaluating the biomolecular interaction between delamanid/formulations and human serum albumin by fluorescence, CD spectroscopy and SPR: Effects on protein conformation, kinetic and thermodynamic parameters;Colloids and Surfaces B: Biointerfaces;2024-07

3. Design of Experiment (DoE) Approach for Developing Inhalable PLGA Microparticles Loaded with Clofazimine for Tuberculosis Treatment;Pharmaceuticals;2024-06-07

4. Current advances in the therapeutic potential of nanomedicines for pulmonary disorders;Emergent Materials;2024-04-24

5. A remodeled ivermectin polycaprolactone-based nanoparticles for inhalation as a promising treatment of pulmonary inflammatory diseases;European Journal of Pharmaceutical Sciences;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3